Unique effect of tetrapentylammonium ions on sympathetic transmission in rat vas deferens
Authors: Huang Y.; Lau C.W.
Source: Journal of Autonomic Pharmacology, Volume 18, Number 3, June 1998 , pp. 189-194(6)
Publisher: Wiley-Blackwell
Abstract:
Summary Effects of tetrapentylammonium ions (TPA+) on contractile responses induced by electric field stimulation and by exogenous agonist such as noradrenaline, ATP and high K+ were examined in the isolated epididymal half of the rat vas deferens. The electrically evoked monophasic contractions (0.5 Hz, 1 ms pulse duration, 40 V) were potentiated by TPA+ at low concentrations (13
M) and inhibited by TPA+ at a concentration greater than 10
M. TPA+ (0.3-3
M) potentiated the contractile responses induced by noradrenaline and ATP, whilst, TPA+ (10
M) concentration-dependently reduced the agonist-induced contractions. TPA+ (0.3
M) potentiated 30 mM K+ -Induced phasic contraction which was inhibited by pretreatment with
,
-methylene ATP (3
M) and prazosin (3
M). TPA+ (10-300
M) reduced the contractions induced by 100 mM extracellular K+ while TBA+ and TEA+ had no effect. The present results show that TPA+ at low concentrations may act at prejunctional nerve membranes to enhance release of contractile transmitters and act as a putative K+ channel blocker at postjunctional membranes to increase muscle contractility in rat vas deferens; whilst at high concentrations TPA+ mainly acts on smooth muscle probably as a non-selective relaxant against the agonist-induced contraction probably through inhibition of Ca2+ influx; this inhibitory effect appears unique for TPA+ since TEA+ and TBA+ did not induce muscle relaxation.
Document Type: Research article
DOI: http://dx.doi.org/10.1046/j.1365-2680.1998.1830189.x
Affiliations: 1: Department of Physiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong, China
Publication date: 1998-06-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Huang Y. ; Lau C.W.

Shopping cart
Receive new issue alert
Get Permissions